American Century Companies’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
Other funds holding CATX
TCM
CC
APM
AAA
SSC
American Century Companies's CATX Position: Q2 2026 in Review
American Century Companies increased its Perspective Therapeutics (CATX) stake by 239% in Q2 2026, buying an estimated $322K and bringing the position to 121,048 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #2630.
American Century Companies first reported a position in CATX in Q4 2025 and has held it in 3 quarters since. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.
- American Century Companies held 121,048 shares of Perspective Therapeutics worth $413K as of Q2 2026.
- American Century Companies bought 85,326 Perspective Therapeutics shares in Q2 2026, an estimated $322K.
- Perspective Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2630 holding.
- American Century Companies first reported a position in Perspective Therapeutics in Q4 2025 and has held it in 3 quarters since.
- 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.